Viewing Study NCT00635193

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:20 AM
Ignite Modification Date: 2026-03-11 @ 8:59 AM
Study NCT ID: NCT00635193
Status: COMPLETED
Last Update Posted: 2013-01-18
First Post: 2008-03-05
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Efficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin)
Sponsor: AbbVie (prior sponsor, Abbott)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer, Primary Peritoneal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ovarian neoplasms View
None Angiogenesis inhibitors View
None Angiogenesis View
None Volociximab View
None Ovarian cancer View
None Antibody View
None Monoclonals View